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ABSTRACT 
A simple, rapid, sensitive and accurate spectrophotometric method for the determination of 
isoniazid in urine has been developed. The method is based on the formation of an orange 
yellow colour complex between isoniazid and ammonium metavanadate in an acid medium (pH 
= 1.80 - 2.20). The resulting complex is stable for 12 hours  and has an absorption maximum at 
420 nm. Beer's law is obeyed in the concentration range of 1.37 - 13.70 µg/ml (R2 = 0.998) with 
limit of detection (LOD) being 0.28µg/ml. The molar absorptivities were1.5.104 l.mol-1.cm-1. 
This method was applied to the determination of isoniazid acetylation rates (phenotypes) in 
healthy volunteers, patients with hepatitis B and diabetes type 2. 
Keywords: N-acetyltransferase 2 (NAT2), acetylation phenotype, isoniazid, spectrophotometry, 
urine.  
1. INTRODUCTION 
The acetylation is an important process of conjugate in phase II metabolism of drugs 
containing amine functional groups, especially aromatic amines as procainamide, hydralazine, 
dapson, sunfanilamide, sulfasalazine, mesalazine, isoniazid and other drugs. The bimodal 
distribution is characteristic of this process, and expressesthefast and slow metabolic rates. The 
difference of the metabolism rate in the acetylation is because of the difference in activity of the 
enzyme N-acetyltransferase (NAT) and is present in the liver and genetic characteristics of the 
human race throughout the world [1, 2]. 
Isoniazid (INH) is one of the main drugs which are effective in theprevention and treatment 
of tuberculosis (TB). So far, isoniazid and rifampicin, ethambutol, pyrazinamide, streptomycin 
and thiacetazone remain the essential drugs to treat this disease. After entering the body orally, 
isoniazid is absorbed rapidly and completely from the gastrointestinal tract. In humans, under the 
action of the enzyme N-acetyltransferase 2 (NAT2), the main products of isoniazid is 
metabolizationare acetyl isoniazid and diacetylhydrazine (Figure 1) [3, 4]. 
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Figure 1. Diagram of isoniazid metabolization in the human body [5]. 
To determine the N-acetylation phenotype in humans with isoniazid,several authors have 
evaluated the half-life of isoniazid (T1/2), concentration of isoniazid, the ratio of acetyl isoniazid 
content and isoniazid, "AINH / "INH" in different biological solutions(plasma, saliva) (Table 1).  
 
Table 1. Results of determining the acetylation of isoniazid. 
 
The dose (oral) Sampling time Biological 
solution Fast acetylation Slow acetylation 
Refer
ences 
450 mg / human 
body 
6 hours after 
ingestion Urine 
% free INH≤ 7 
 
% free INH > 7 
 
[1] 
5 mg/kg human 
body 
6 hours after 
ingestion Plasma Т1/2 ≤110 min Т1/2 ≥ 120 min 
[5] 
10 mg/kg human 
body 
12 hours after 
ingestion Plasma Т1/2≤110 min Т1/2> 110 min 
10 mg/kg human 
body 
6 hours after 
ingestion Plasma СINH <2,5 µg/ml СINH ≥2,5 µg/ml 
20 mg/kg human 
body 
3 hours after 
ingestion Urine 
AINH
INH
≥ 1,18 AINH
INH
<0,36 
5 mg/kg human 
body 
3 hours after 
ingestion Plasma 
AINH
INH
>0,7 AINH
INH
≤0,7 [6] 
200 mg/ human 
body 
6 hours after 
ingestion 
Saliva and 
Plasma Т1/2<130 min Т1/2> 130 min [7] 
 
 
200 mg/ human 
body 
3 hours after 
ingestion 
Saliva and 
Plasma 
AINH
INH
>1,5 AINH
INH
<1,5 
10 mg/kg human 
body 
3 hours after 
ingestion Plasma 
AINH
INH
≥ 0,48
 
AINH
INH
<0,48 [8] 
However, the determination of N-acetylation phenotype according to the above methods 
encounter some disadvantages. For instance,  the process to handle the samples is complicated or 
it needs accurate kinematic studies of the metabolism of isoniazid. On the other hand, the 
analysis method requires to have high sensitivity using expensive equipment such as high-
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performance liquid chromatography with different detectors (HPLC-UV, PDA, MS, MS / MS). 
The determination of acetylation based on the percentage of excreted isoniazid in urine [1] by 
spectrophotometric method has some advantages like simple sample preparation techniques, 
analysis method of high sensitivity and accuracy. 
Determinations of isoniazid medicines and biological solutions by spectrophotometric 
methodsare based on the use of organic reagents: 4 dimethylaminobenzaldehyde, 7-chloro-4,6 
dinitrobenzofuroxan, 2,4,6-Trinitrobenzenesulfonic acid, mixtures of Fe (III) and 1,10 - 
phenanthroline, a mixture of Cu (II),thiocyanate ion and reagent 4-(2-pyridylazo) resorcinol 
(PAR), a mixture of Cu (II) and neocuproin ... However, the disadvantages of using these 
reagentsare that the reaction is often conducted through many phases and lasts a long time[9]. 
In this paper, we determined the percentage of isoniazid excreted in urine based on 
complex formation with ammonia metavanadate reagents in an acidic medium by 
spectrophotometric method. We have applied this method to determine the acetylation 
phenotype in healthy volunteers as well as patients with type 2 diabetes and hepatitis B. 
2. EXPERIMENTAL 
2.1. Chemicals and equipment 
The chemicals used in the study were very pure for effective analysis. Isoniazid 99% and 
99% metavanadate ammonium reagents were purchased from the company Sigma-Aldrich 
(USA), sulfuric acid, isoniazid products by the pharmaceutical company Semashko (Russia).  
Original isoniazid solution (1.37 mg/ml) was prepared by weighing an exact amount of 
isoniazid and then dissolving it in a carefully measured amount of ethanol. A less concentrated 
solution was prepared from a stock solution by diluting it with ethanol. 0.2 % ammonium 
metavanadate reagentin 2 % H2SO4 solution was mixed from equal exactly weight of 
metavanadatethen dissolving it in 2M H2SO4 solution. 
All spectrophotometric measurements were performed on the UV-Visible recording 
spectrophotometer SPECORD® 50 (Germany) using 1 cm quartz cuvettes. Hanna HI 2211 pH 
meter (Romania) was calibrated daily by standard solutions with pH = 4.00 and pH = 7.00 
before measuring. 
2.2. Construction of calibration curve 
Take 0.3 ml of urine which does not contain isoniazid in the 10 ml volumetricflask, adding 
standardized isoniazid solution to get concentrations in urine solution of 0; 1.37; 2.74; 5.48; 
8.22; 10.96; 13.70 µg /ml. Then add to each volumetricflask 2 ml of 0.2 % ammonium 
metavanadate in a solution of 2 % H2SO4 and norms to the mark with twice distilled water. 
Comparative solutions were also prepared similarly to the above with no additional conditions 
for isoniazid standard solutions. The absorbance of the studied solution was then measuredat 420 
nm. Calibration was set for each studied subject. 
2.3. Preparation of solutions 
Each volunteer drank 450 mg isoniazid with 200ml of pure water. Urine samples were 
collected at times of 0, 2, 4 and 6 hours after taking isoniazid.Research solutions as well as 
reference solution were prepared in 10 mlvolumetric flasks. Take 0.3 ml of urine from 
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volunteers in 10 ml flask, add 2 ml into a bottle of 0.2% ammonium metavanadate reagent in 2% 
H2SO4 solution and fill to themark with twice distilled water. Comparative solutions were also 
prepared in a similar way as the study fluid, addingurine which does not contain isoniazid. Then, 
the measurement of the optical density at 420 nm of research solutions were compared to 
therespective solutions. 
2.4. Statistical analysis 
The limit of detection (LOD) and quantification (LOQ) of the method are given by3. SD
b
and 
10.
SD
b
 respectively, relative standard deviation (RSD (%))= SD
X
. 100.;  where SD is the standard 
deviation, b is the slope of the calibration curve equation, X" is the average value of the 
measurement.Calculation and processing of data were done using the programs Statistica 6 (US) 
and MS Office 2007 (Excel). 
2.5. Volunteers 
One hundred and ten healthy volunteers (50 male and 60 female) were chosen for the study. 
They are all Russian citizens with an average age of 23 years (range 20 - 35 years), the average 
height of 165 cm (range 153 - 185 cm), and an average weight of 63 kg (range 55 - 92 kg). None 
of the volunteers has chronic diseases (liver, kidneys, digestive ...), they do not smoke, do not 
use the drugs, drink neither alcohol nor caffeine containing beverages both before and during the 
study. 
Twenty-four patients with hepatitis B status (14 male and 10 female), average age 37 years 
(range from 21 - 51 years old), the average height of 173 cm (range 151 - 193 cm), average 
weight of 75 kg (range 53 – 109 kg). 
Sixty-one patients with type 2 diabetes (17 male and 44 female) with disease duration from 
1 - 24 years, average age 63 years (range from 47 - 78 years old), the average height of 168 cm 
(range 150 - 182 cm), the average weight of 67 kg (range 58 – 82 kg). 
3. RESULTS AND DISCUSSION 
3.1. Electronic absorption spectra of the complex between isoniazid and the ammonium 
metavanadate reagent 
Electronic absorption spectra of ammonium metavanadate reagents, urine (does not contain 
isoniazid) with ammonium metavanadate reagents and research solution (complex between 
izoniazid and ammonium metavanadate reagent) at pH = 2.00 is shown in Figure 2. The results 
show that compared with the electronic absorption spectrum of ammonia metavanadate reagent 
and the urine (containing noisoniazid) with ammonium metavanadate reagents, the peak of 
electronic absorption spectrum of research solution shifts to a longer wavelength region and 
reaches the maximum value at λmax= 420 nm. At this wavelength, the influence of reagents and 
urinary constituents on electronic absorption spectrum of research solutions is negligible. In the 
next experiment, we measured absorption of the solution study at the optimal wave length of 420 
nm. 
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Figure 2. The absorption spectra: 1-Reagent ammonium metavanadate (1.7.10-2M, pH = 2.00),  
2-Urine (containing no isoniazid) with ammonium metavanadate reagent (4.10-3M, pH = 2.00),  
3-Research solution (pH = 2.00). 
3.2. Optimal conditions for the complex formation between isoniazid and ammonium 
metavanadatereagent 
The absorption spectra of research solutions at different pH values (Figure 3) show that the 
electronic absorption spectrum of the complex between isoniazid and ammonium metavanadate 
reagent is formed at low pH values (1.80 to 2.20) and the maximum absorbance at 420 nm. As 
pH increased, the optical density of the solution reduced and when the pH = 6.86 research 
solution gave the absorption intensity shifted to shorter wavelengths. In the next study, we used 
2 % H2SO4 solution to maintain optimal pH value. Using the method of continuous variations 
and mol ratio,we defined complex components in a ratio of 1:1, stable complex after 10 minutes 
preparation and stable complex for 12 hours  after preparation. 
 
Figure 3. The absorption spectra of complexes between isoniazid (10-4M) and ammonium metavanadate 
reagent (4.10-3M) at different pH values: 1- pH 2.20; 2- pH = 4.50; 3- pH = 6.86; 4- pH = 7.50. 
3.3. Validation of analytical methods 
Concentrations obeying Beer's law (µg/ml) range from1.37 to 13.7, the calibration 
equationis A = 0.0533Cx (µg/ml) + 0.0007. The correlation coefficient R2 = 0.998, and the 
relative standard deviation (RSD (%)) = 2.16 %. The molar absorption coefficient of the 
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complex ε = 1.5.104l.mol-1.cm-1. The limit of detection (LOD) = 0.28 (µg/ml)and the limit of 
quantitation (LOQ) = 0.94 (µg/ml). 
Table 2. Accuracy of quantitative evaluation of isoniazid in the urine samples by spectrophotometric 
method (n = 4, p = 0.95). 
INH taken 
(µg/ml) 
INHfound 
(µg/ml) 
RSD(%) 
1.37 1.36 ± 0.02 1.5 
2.74 2.75 ± 0.25 1.5 
5.48 5.41 ± 0.27 2.4 
8,22 8.02 ± 0.25 3.6 
10.96 10.83 ± 0.26 1.8 
Thus, using spectrophotometric method for determination of isoniazid in the human urine 
meets the standardization of analytical methods of substances in biological fluids. So, we can 
use the method developed above to determine acetylation phenotype in human volunteers. 
3.4. Applying analytical methods to determine the acetylation phenotype in human 
volunteers 
To classify the volunteers having fast or slow acetylated speed (≤ 7 (> 7) one uses the 
isoniazid percent excreted in urine after 6 hours [1]. Results ofthe distribution percentage of fast 
and slow acetylation phenotype in healthy volunteers and patients with type 2 diabetes and 
hepatitis B are shown in Table 3 and Figure 4. 
Table 3. Results of classifying NAT-2 enzyme activity by isoniazid in healthy volunteers,  
patients with hepatitis B and diabetes type 2 (Mean ± SD). 
Acetylation 
phenotype 
NAT activity (Percent excreted of isoniazid,%) 
Healthy volunteers 
(n=110) 
Patients with 
hepatitis B (n=24) 
Patients with type 2 
diabetes  
(n = 61)  
Fast 3.12±0.25 4.48±0.56 4.80±0.80 
Probability 
distributions p<0.001 p<0.001 p<0.001 
Slow 9.40± 1.37 11.35±1.95 13.50±1.50 
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Figure 4. Distribution of acetylation phenotypes: 1 -healthy volunteers (n = 110) 
2- type 2 diabetes patients (n = 61), 3- hepatitis B patients (n = 24). 
The results in Table 3 and Figure 4 indicate that after 6 hours, the percentage of free 
isoniazid excreted in the healthy volunteers of fast rate metabolism and slow acetylation are 3.12 
± 0.25 % and 9,40 ± 1.37 % (p < 0.001), respectively. Fast and slow acetylation accounted for 
45 % (n = 50) and and 55 % (n = 60), respectively. These results are similar to those reported in 
[1].16 hepatitis B patients showed fast acetylation rate (67 %) and 8 patients showed slow 
acetylation rate (33 %). Thus, the rapid acetylation in patients with hepatitis B prevailed and 
increased 22 % compared to healthy volunteers. For patients with type 2 diabetes we observed 
38 patients with fast acetylation rate (62 %) and 23 patients with a slow  rate (38 %). Thus, 
similar to patients with hepatitis B, fast acetylation phenotype in patients with type 2 diabetes is 
also dominant (63 %) and an increase of 18 % compared to healthy volunteers. This can be 
explained by the reduction in the metabolism of fatty acids synthesis from acetyl coenzyme A 
(consequences of insulin deficiency). 
We ascertained that acetylation speed depends on disease duration for diabetic patients by 
classifying patients with disease duration of over and under 10 years (Figure 5). For patients 
with type 2 diabetes with disease duration less than 10 years, we observed no differences 
between fast and slow acetylation phenotype (53 and 47 respectively %) (p > 0.05). However, 
patients with disease duration of 10 years or more tend to increase faster metabolism of patients 
(72 %), this can be explained by the metabolic carbohydrates in the body, thereby causing N-
acetyltransferase enzyme induction 2 and increases the metabolic rate faster acetyl in these 
patients. 
 
Figure 5. Distribution of acetylation phenotype as dependent on diabetes duration: 
1 - healthy volunteers (n = 110), 2- under 10 years, 3 -on 10 years. 
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4. CONCLUSIONS 
Our study shows that the ability to use ammonium metavanadate as reagents to determine 
the amount of isoniazid excreted in urine has many advantages such as not requiring expensive 
equipment, and boasting analytical methods which are rapid, selective and relatively sensitive. 
Therefore, this method may be applied to determine phenotypic acetylation and pharmacokinetic 
study of isoniazid excreted in human volunteers. 
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TÓM TẮT  
XÁC ĐỊNH HÀM LƯỢNG ISONIAZID TRONG NƯỚC TIỂU NGƯỜI BẰNG PHƯƠNG 
PHÁP TRẮC QUANG 
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Phương pháp đơn giản, nhanh, nhạy và chính xác đã được xây dựng để xác định isoniazid 
trong nước tiểu bằng phương pháp trắc quang. Cơ sở của phương pháp dựa trên sự hình thành 
phức màu vàng cam giữa isoniazid với thuốc thử amoni metavanadat trong môi trường axit (pH 
= 1,80 - 2,20). Phức hấp thụ cực đại tại 420 nm và bền trong khoảng 12 giờ sau khi chuẩn bị. 
Khoảng nồng độ tuân theo định luật Bia là 1,37 - 13,7(µg/ml),  giới hạn phát hiện (LOD) là 0,28 
µg/ml, hệ số hấp thụ mol của phức ε = 1,5.104  l.mol -1.cm-1. Phương pháp đã được áp dụng để 
xác định kiểu hình acetyl hóa ở người tình nguyện khỏe mạnh, bệnh nhân viêm gan B và tiểu 
đường loại 2. 
Từ khóa: N-acetyltransferase 2 (NAT2), kiểu hình acetyl hóa, isoniazid, trắc quang, nước tiểu. 
 
 
